Kimberly Wolf Email & Phone Number
@celgene.com
3 phones found area 732, 908, and 785
LinkedIn matched
Who is Kimberly Wolf? Overview
A concise factual answer block for searchers comparing this professional profile.
Kimberly Wolf is listed as Global Biotech & Pharmaceutical Executive—Commercial Strategy and Execution and Drug Development at BeiGene, based in Summit, New Jersey, United States. AeroLeads shows a work email signal at celgene.com, phone signal with area code 732, 908, 785, and a matched LinkedIn profile for Kimberly Wolf.
Kimberly Wolf previously worked as SVP Global Commercial Strategy and Operations at Beigene and Vice President, Global Hematology, Lung and Precision Medicine Franchise Lead at Pfizer. Kimberly Wolf holds Mph, Public Health from University Of North Carolina At Chapel Hill.
Email format at BeiGene
This section adds company-level context without repeating Kimberly Wolf's masked contact details.
AeroLeads found 1 current-domain work email signal for Kimberly Wolf. Compare company email patterns before reaching out.
About Kimberly Wolf
Dynamic, results-focused senior pharmaceutical leader with demonstrated success in biotechnology and traditional pharmaceutical businesses. Strong global and US commercial experience on products with sales ranging from $150M to >$1B. Proven results leading pharmaceutical product/drug development teams Phase II through launch and LCM. Lead and build large teams, develop markets and commercial strategies in a range of therapeutic areas (experience in more than 20 indications, including hematology, oncology and cell therapy); global commercial strategy, product launches, lifecycle planning, and commercial leadership through all stages of product lifecycle. Adept at driving complex organizational transformation via direct and matrix organizations. High EQ, people management/interpersonal and communication skills.Therapeutic experience includes: hematology, oncology, cell therapy, dermatology (psoriasis, atopic dermatitis), rheumatology (psoriatic arthritis, ankylosing spondylitis, Behcet's disease), IBD (ulcerative colitis, Crohn's disease, EOE), virology (hepatitis and HIV), cardiovascular disease and CNS.
Kimberly Wolf's current company
Company context helps verify the profile and gives searchers a useful next step.
Kimberly Wolf work experience
A career timeline built from the work history available for this profile.
Vice President, Global Hematology, Lung And Precision Medicine Franchise Lead
Vp, Worldwide Commercial Cell Therapy Franchise Head (Car T)
Led the worldwide commercial cell therapy franchise, including creating and implementing global strategy for Breyanzi and Abecma, with US, EU and Japan launches in 2021. Oversaw brand, franchise marketing and operations teams across all indications and markets.
Vp, Worldwide Lymphoma Commercial Strategy
Joined BMS’s hematology organization following the $74B acquisition of Celgene in late 2019. Developed disease and asset strategy for lymphoma and CLL across markets and functions, including BD and overall commercial strategy (including patient identification) for molecular diagnostics.
Vp Head Of Project Leadership, I&I At Celgene
Provided leadership, direction and decision-making, and drove cross-functional execution of all I&I assets by leading a group of development project leaders and project managers across different therapeutic areas: dermatology, rheumatology, gastroenterology and fibrosis; assets ranged from proof-of-concept through lifecycle management.
Project Leader
Project Leader for Otezla (rheumatology and dermatology)Project Leader for GED-0301 (Crohn's disease and ulcerative colitis)
Head Of Global Otezla Marketing, I&I
Built and led Global Marketing team for Otezla across six indications and one formulation (PsO, PsA, AS, AD, BCT, UC and QD), in various stages of development from Phase II through global launches in psoriatic arthritis and psoriasis. Led integrated pre-launch/launch activities across psoriatic arthritis and psoriasis through launches in all key markets; Otezla hit >$1 billion sales two years post launch—ahead of all competitor analogs
Executive Director, I&I, Cr&D
Joined newly formed Inflammation and Immunology business unit within Celgene pre-Phase 3 data to advance infrastructure and communication related to lead compound.
Head Of Americas Marketing, Marketing Services And Market Research, Medical Diagnostics
Directed marketing, marketing services and market research teams for US, Latin American and Canada—spanning nine pharmaceutical (diagnostic) products with $850M combined revenue), across a multiple of therapeutic areas, including cardiovascular, neurology and oncology; major modalities include X-ray, MRI, Ultrasound and Molecular Imaging.
Commercial Lead Hepatitis B Business Unit
US Commercial Lead for Baraclude Business Unit, #1 antiviral for chronic hepatitis B. Responsible for marketing, sales and advocacy—team of 50, driving commercial strategy and operations across all channels. Managed full P&L.
Brand Lead, Reyataz
US Marketing Brand Lead for Reyataz, #1 protease inhibitor utilized in combination with other antiretroviral products--team of 8. Responsible for driving all commercial activities for the brand, including global responsibilities; projected US sales of more than $900 million year-end 2009—double digit growth YOY.
Director, Global Marketing, Baraclude
Global lead for EU pre-launch/launch, Lifecycle Management, Public Relations and Strategic Planning. Aligned strategies with key global brand business opportunities and operationalized key components of EU plan. Corporate marketing coach for competitive and lifecycle planning.
Director, Global Marketing, Edifoligide (Cardiovascular)
Global lead for cardiothoracic pre-launch activities for specialty product in Phase III development (product failed Phase III trial) (in conj with JV partner).
Associate Director, Global Marketing (Cardiovascular)
Drove commercialization assessment and strategy for Phase II (product failed) and early development thrombosis compounds.
Additional Experience
Company acquired by Pfizer in 2003. Earned a series of promotions working across CNS and urology products. -SPM/Associate Director, Detrol LA (overactive bladder)-SPM, CNS Products-Market Manager, CNS
Kimberly Wolf education
Mph, Public Health
Ba, Journalism
Frequently asked questions about Kimberly Wolf
Quick answers generated from the profile data available on this page.
What company does Kimberly Wolf work for?
Kimberly Wolf works for BeiGene.
What is Kimberly Wolf's role at BeiGene?
Kimberly Wolf is listed as Global Biotech & Pharmaceutical Executive—Commercial Strategy and Execution and Drug Development at BeiGene.
What is Kimberly Wolf's email address?
AeroLeads has found 1 work email signal at @celgene.com for Kimberly Wolf at BeiGene.
What is Kimberly Wolf's phone number?
AeroLeads has found 3 phone signal(s) with area code 732, 908, 785 for Kimberly Wolf at BeiGene.
Where is Kimberly Wolf based?
Kimberly Wolf is based in Summit, New Jersey, United States while working with BeiGene.
What companies has Kimberly Wolf worked for?
Kimberly Wolf has worked for Beigene, Pfizer, Bristol Myers Squibb, Celgene, and Ge Healthcare.
How can I contact Kimberly Wolf?
You can use AeroLeads to view verified contact signals for Kimberly Wolf at BeiGene, including work email, phone, and LinkedIn data when available.
What schools did Kimberly Wolf attend?
Kimberly Wolf holds Mph, Public Health from University Of North Carolina At Chapel Hill.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial